Navigation Links
The Female Health Company Reports Record Fourth Quarter and FY2012 Operating Results
Date:12/4/2012

ncreased 232% to a record $10.9 million in the fiscal year ended September 30, 2012, compared with $3.3 million in FY2011. The increase was due to higher revenue and gross profit margins in FY2012.

The Company reported record net income of $15.3 million, or $0.53 per diluted share, in the fiscal year ended September 30, 2012, for an increase of 183% when compared with net income of $5.4 million, or $0.19 per diluted share, in the fiscal year ended September 30, 2011. The Company recorded currency losses of $0.15 million and $0.06 million in the fiscal years ended September 30, 2012 and 2011, respectively.  The Company recorded a net tax benefit for FY2012 of $4.5 million, versus $2.2 million in FY2011.  The Company has tax loss carryforwards of $24.6 million Federal, $12.4 million state and $64.3 million in the U.K., to offset future earnings.

During the fiscal year ended September 30, 2012, the Company generated positive cash flow from operations of approximately $10.4 million, paid two quarterly cash dividends of $0.05 per share each and two quarterly cash dividends of $0.06 per share each, self-funded plant capacity expansion, and maintained a debt-free balance sheet.  The amount of cash on the Company's balance sheet increased 25% during FY2012, to $5.3 million as of September 30, 2012, versus $4.2 million as of September 30, 2011.  The Company's annualized cash dividends of $0.24 at the current dividend rate provides shareholders with a current yield of 3.3% based upon the closing price of FHCO shares on December 3, 2012.

"As noted in previous press releases, timing issues regarding the receipt and shipment of large orders can significantly impact the Company's operating results, positively or negatively, illustrating the difficulty of providing specific revenue and operating income guidance," added Parrish. "Management intends to provide general comments each quarter regarding the Company's outlook, based on information
'/>"/>

SOURCE The Female Health Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. The Female Health Company to Report FY2012 Operating Results on Tuesday, December 4, 2012
2. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
3. Attorneys for Class of Female VPs and SVPs Employed by PR Giant MSLGroup Clarify Companys Inaccurate Description of Federal Courts Recent Certification Ruling
4. The Female Health Company Reports Second Quarter Operating Results
5. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
6. Depomed To Present At Oppenheimer 2012 Healthcare Conference
7. Premier Healthcare Alliance Awards 3-Year Group Purchasing Contract for Diaper and Adult Brief Waste Receptacles to Sinclair Worldwide
8. U.S. News & World Report and Pharmacy Times Introduce New Pharmacist-recommended Health Product Website
9. ClinicalKey Key Innovator Award to Recognize the Innovative Use of Health Information and Technology to Save and Improve Lives
10. Frost & Sullivan: Investments in Healthcare Improvements to Bolster the Integration of Picture Archiving and Communications Systems in Latin America
11. Affluence, an Aging Population, and Anticipated Rx-to-OTC Switches Boost a Healthy $32 Billion OTC Market in China, According to Kline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 6, 2015  Impax Laboratories, Inc. (NASDAQ: IPXL ... second quarter 2015 financial results on Monday, August 10, ... markets. The Company will host a conference call and ... Eastern Time on August 10, 2015. The ... the Investor Relations section of the Company,s Web site ...
(Date:7/6/2015)... HORSHAM, Pa. , July 6, 2015 /PRNewswire/ ... procedure-based, bone fixation concept the FlowerCube™, announced today ... approval opens the opportunity for significant expansion of ...   The approval encompasses Flower Orthopedics, ... fixation solutions for upper and lower extremities. Consisting ...
(Date:7/6/2015)... NEWTOWN, Pa. , July 6, 2015 /PRNewswire/ ... services and technology provider, today announced that it ... retention firm, MediciGroup ® , Inc. (Medici).  The ... Access to Patients, LLC.  Medici also provides a ... finds missing patients globally.  Together with Medici, ...
Breaking Medicine Technology:Impax to Report Second Quarter 2015 Results on August 10, 2015 2Flower Orthopedics cleared to enter the European Union 2BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3
... presented this week at the International Federation of Clinical ... lower diagnostic threshold for troponin improves clinical outcomes and ...  Troponin is a protein found inside of heart cells ... or reduced blood supply.   Cardiac troponin ...
... Neuro Kinetics, Inc. (NKI) ( www.neuro-kinetics.com ), ... for neuro-physiologic, neuro-otologic, vestibular and neurological testing, said ... its VEST™ control and analysis software. ... software to conduct vestibular, oculomotor and optokinetic tests ...
Cached Medicine Technology:Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay 2Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay 3Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay 4Neuro Kinetics Releases Updated Version of Neuro-Otologic Control and Analysis Software 2
(Date:7/7/2015)... ... July 07, 2015 , ... ... strong managerial expertise to oversee large healthcare operations and their success is ... partners, insurance companies, and regulators. American Sentinel University, an innovative, accredited provider ...
(Date:7/7/2015)... ... July 07, 2015 , ... On May 29, 2015, Health Canada ... the use of gluten-free claims for gluten free oats and foods that contain them ... Gluten-Free Certification Program (GFCP) to include gluten-free oat products in Canada,” says Frank ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... today announced they have been selected by the Department of Vermont Health Access ... its Medicaid Management Information System (MMIS) and Integrated Contact Center System project. , ...
(Date:7/6/2015)... ... July 06, 2015 , ... Human induced pluripotent ... iPSCs are generated from adult cells, such as blood or skin, can replicate ... human body. , iPSC-derived cardiomyocytes have proven valuable in helping ...
(Date:7/6/2015)... ... July 06, 2015 , ... University of Pittsburgh Cancer Institute ... thyroid cancer testing to reflect newly available tests that better incorporate personalized medicine into ... to interpret thyroid cancer tests is published in the July issue of the scientific ...
Breaking Medicine News(10 mins):Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 3Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 4Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 4Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 2Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 3Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 5
... leads (Medtronic) failed more often in younger patients, women, ... multicenter study published online Jan. 17 in Circulation ... associated with death or serious injuries. ... experienced painful inappropriate shocks, according to lead author Robert ...
... of the E2F transcription factor family, and plays a key ... been reported in various human cancers, but not in liver ... not known whether E2F5 plays a tumor suppressor role or ... the expression profile of E2F5 in HCC and its biological ...
... life be easy if everything happened as we anticipated? In ... using an inbuilt network that makes predictions about the world ... the front of the brain, called the orbitofrontal cortex, plays ... damage to this area confuse memories with reality and continue ...
... in the journal Clinical Cardiology reveals that a Super ... rates in both men and women and in older individuals. , ... When the team loses, it can cause some degree of emotional ... Heart Institute, Good Samarian Hospital and Keck School of Medicine at ...
... Dennis Thompson HealthDay Reporter , FRIDAY, Jan. ... concerns over a decision by a drug manufacturer to ... of the medication,s use in lethal injections in prison ... to produce Pentothal (sodium thiopental) at its plant in ...
... HOUSTON - Practicing stress management techniques before prostate cancer ... to quicker recovery, as well as aid in lowering ... at The University of Texas MD Anderson Cancer Center. ... edition of the journal Psychosomatic Medicine . It,s ...
Cached Medicine News:Health News:Recalled ICD leads fail in women, youths most often 2Health News:Revealing the wiring that allows us to adapt to the unexpected 2Health News:Will Loss of Lethal Injection Drug Harm Surgical Patients? 2Health News:Will Loss of Lethal Injection Drug Harm Surgical Patients? 3Health News:Pre-surgical stress management boosts immune function, lowers mood disturbance in prostate cancer patients 2Health News:Pre-surgical stress management boosts immune function, lowers mood disturbance in prostate cancer patients 3
VG1 ALIF (Anterior Lateral) Anterior lumbar interbody fusion. Frozen freeze-dried preservation....
Allograft implants can be easily used to repair and promote the healing of a wide variety of bone and other tissue defects....
Allograft implants can be easily used to repair and promote the healing of a wide variety of bone and other tissue defects....
Duet Lumbar Allografts are comprised of a raised cancellous inner core providing biomechanical properties for rapid healing. Specially designed instruments facilitate the insertion of Duet Allografts...
Medicine Products: